That slump has driven its dividend yield up to more than 5%. While Kenvue stock is down this year, it could soar in 2026.

More than 3,000 U.K. claimants accuse U.S. pharmaceutical giant Johnson & Johnson of knowingly selling asbestos-tainted talcum powder, making them ill.

Johnson & Johnson (NYSE:JNJ) is one of Ray Dalio’s latest top stock positions. On October 7, a Los Angeles jury ordered ...

The multibillion-dollar corporation is still grappling with lawsuits from more than 62,000 claimants in the US alleging its ...

More than 3,000 people in Britain have joined a lawsuit accusing the company of knowing that its baby powder contained ...

Breaking up isn’t so hard to do, after all. Just two years after spinning off its consumer products as Kenvue Inc., Johnson & ...

Johnson & Johnson’s stock rose toward a record after a beat-and-raise earnings report and announcement of plans to separate ...

The sale of baby powder containing talc stopped in the UK in 2023. The UK action mirrors extensive litigation in the US, ...

The case involves a California woman who died from mesothelioma, a rare cancer. Her family claimed Johnson and Johnson’s talc ...

(Reuters) -A Los Angeles jury ordered Johnson & Johnson to pay $966 million to the family of a woman who died from ...

The planned separation is the latest move by J&J to slim down in recent years and focus on faster-growing businesses.

Thousands in the UK sue Johnson & Johnson over asbestos-linked talc. The £1 billion lawsuit could award victims up to ...